2i5x: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2i5x.png|left|200px]] | [[Image:2i5x.png|left|200px]] | ||
{{STRUCTURE_2i5x| PDB=2i5x | SCENE= }} | {{STRUCTURE_2i5x| PDB=2i5x | SCENE= }} | ||
===Engineering the PTPbeta catalytic domain with improved crystallization properties=== | ===Engineering the PTPbeta catalytic domain with improved crystallization properties=== | ||
{{ABSTRACT_PUBMED_17139078}} | {{ABSTRACT_PUBMED_17139078}} | ||
==About this Structure== | ==About this Structure== | ||
[[2i5x]] is a 2 chain structure of [[Proten tyrosine phosphatase]] and [[Tyrosine phosphatase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2I5X OCA]. | |||
==See Also== | |||
*[[Proten tyrosine phosphatase|Proten tyrosine phosphatase]] | |||
*[[Tyrosine phosphatase|Tyrosine phosphatase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:017139078</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Protein-tyrosine-phosphatase]] | [[Category: Protein-tyrosine-phosphatase]] | ||
| Line 32: | Line 24: | ||
[[Category: Walter, R L.]] | [[Category: Walter, R L.]] | ||
[[Category: Drug design]] | [[Category: Drug design]] | ||
[[Category: Hydrolase]] | |||
[[Category: Protein engineering]] | [[Category: Protein engineering]] | ||
[[Category: Protein tyrosine phosphatase]] | [[Category: Protein tyrosine phosphatase]] | ||
[[Category: Wpd-loop]] | [[Category: Wpd-loop]] | ||
Revision as of 23:01, 25 July 2012
Engineering the PTPbeta catalytic domain with improved crystallization properties
Template:ABSTRACT PUBMED 17139078
About this Structure
2i5x is a 2 chain structure of Proten tyrosine phosphatase and Tyrosine phosphatase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Evdokimov AG, Pokross M, Walter R, Mekel M, Cox B, Li C, Bechard R, Genbauffe F, Andrews R, Diven C, Howard B, Rastogi V, Gray J, Maier M, Peters KG. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. Acta Crystallogr D Biol Crystallogr. 2006 Dec;62(Pt 12):1435-45. Epub 2006, Nov 23. PMID:17139078 doi:https://dx.doi.org/10.1107/S0907444906037784